SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro

Hsu, AC-Y Wang, G Reid, AT Veerati, PC Pathinayake, PS Daly, K Mayall, JR Hansbro, PM Horvat, JC Wang, F Wark, PA

Permalink

Open Access

Copyright Clearance Process

This item is open access.

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Hsu, AC-Y
dc.contributor.author	Wang, G
dc.contributor.author	Reid, AT
dc.contributor.author	Veerati, PC
dc.contributor.author	Pathinayake, PS
dc.contributor.author	Daly, K
dc.contributor.author	Mayall, JR
dc.contributor.author	Hansbro, PM
dc.contributor.author	Horvat, JC
dc.contributor.author	Wang, F
dc.contributor.author	Wark, PA
dc.date.accessioned	2022-03-29T03:26:01Z
dc.date.available	2022-03-29T03:26:01Z
dc.date.issued	2020-10-01
dc.identifier.citation	bioRxiv, 2020
dc.identifier.uri	http://hdl.handle.net/10453/155663
dc.language	en
dc.relation.ispartof	bioRxiv
dc.relation.isbasedon	10.1101/2020.09.30.317818
dc.rights	info:eu-repo/semantics/openAccess
dc.title	SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro
dc.type	Preprint
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
utslib.copyright.status	open_access	*
dc.date.updated	2022-03-29T03:25:59Z

Please use this identifier to cite or link to this item: